[Treatment of breast carcinoma. Results of telecobaltherapy associated to surgery (author's transl)].
The study was performed on 156 cases of breast carcinoma treated since 1968 with a follow up of 5 to 9 years. The global actuarial survival in 73,5%. The stages T1 T2 N0 treated by tumor excision gave a prominent result: 93%  5 years survival while preserving the breast. Among grave signs the importance of axillar involvement is outlined: the 5 years survival is 65,5% with N1 M0 while 73,5% with N0 - M0. Local recurrences are  rare (8%) and generally in extensive cases. Sequelae are rare (3 to 13%), the most frequent is the arm lymphodema which is related more to the Halstedt surgical procedure than to post operative irradiation. These results in agreement with other publications emphasize the importance of post operative irradiation. Only in the high risk cases one must try in addition to radiotherapy a chemotherapy treatment.
D000328:Adult; D001365:Axilla; D001940:Breast / Q000601:surgery; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011182:Postoperative Care / Q000379:methods*; D011867:Radioisotope Teletherapy; D012008:Recurrence
D003037:Cobalt Radioisotopes
Traitement du cancer du sein. Résultats de l'association télécobalthérapie-chirurgie chez 156 malades.